Fig. 3From: Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stageBox diagram showing the levels of the PSMC6 (a), SIRT1 (b), and SUZ12 (c) genes. The gene expression levels of PSMC6, SIRT1 and SUZ12 decreased on sequence HD group, preHD group and HC groupBack to article page